Viridian, Vinay Prasad, AI and Medicare

Viridian, Vinay Prasad, AI and Medicare


Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got another busy news day. My colleagues were working hard last night. Let’s get right into that.

Vinay Prasad, top FDA official, exits under pressure

Vinay Prasad, a top official at the Food and Drug Administration, resigned yesterday following a series of controversial decisions regarding a gene therapy from Sarepta Therapeutics and pressure from right-wing activists.

STAT+ Exclusive Story

STAT+





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *